ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 521,612 shares; 2024Q4: 1,513,393 shares; 2025Q1: 2,210,019 shares; 2025Q2: 3,071,340 shares; 2025Q3: 1,350,826 shares; 2025Q4: 1,317,329 shares; 2026Q1: 1,394,019 shares; 2026Q2: 1,804,703 shares 1,804,703 $240M 11.3% +410,684 Timeline PTGX PROTAGONIST THERAPEUTICS INC More: the full row for PROTAGONIST THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 981,295 shares; 2024Q4: 1,020,333 shares; 2025Q1: 939,669 shares; 2025Q2: 948,069 shares; 2025Q3: 989,182 shares; 2025Q4: 1,049,168 shares; 2026Q1: 994,119 shares; 2026Q2: 960,863 shares 960,863 $118M 5.54% -33,256 Timeline ROIV ROIVANT SCIENCES LTD More: the full row for ROIVANT SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,025,450 shares; 2024Q4: 3,508,694 shares; 2025Q1: 3,483,404 shares; 2025Q2: 1,940,797 shares; 2025Q3: 3,347,501 shares; 2025Q4: 3,428,962 shares; 2026Q1: 3,285,906 shares; 2026Q2: 3,157,008 shares 3,157,008 $112M 5.25% -128,898 Timeline SPY STATE STR SPDR S&P 500 ETF T More: the full row for STATE STR SPDR S&P 500 ETF T Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,684 shares; 2025Q3: 54,684 shares; 2025Q4: 54,684 shares; 2026Q1: 75,940 shares; 2026Q2: 129,087 shares 129,087 $96.4M 4.53% +53,147 Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,131,707 shares; 2024Q4: 787,478 shares; 2025Q1: 968,866 shares; 2025Q2: 535,066 shares; 2025Q3: 2,241,753 shares; 2025Q4: 2,480,968 shares; 2026Q1: 2,679,010 shares; 2026Q2: 2,330,716 shares 2,330,716 $89.8M 4.22% -348,294 Timeline ZLAB ZAI LAB LTD More: the full row for ZAI LAB LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 532,454 shares; 2024Q4: 1,045,837 shares; 2025Q1: 940,858 shares; 2025Q2: 850,437 shares; 2025Q3: 868,780 shares; 2025Q4: 1,246,520 shares; 2026Q1: 1,425,367 shares; 2026Q2: 3,369,034 shares 3,369,034 $64M 3.01% +1,943,667 Timeline AGIO AGIOS PHARMACEUTICALS INC More: the full row for AGIOS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 21,300 shares; 2024Q4: not reported; 2025Q1: 27,900 shares; 2025Q2: 35,900 shares; 2025Q3: 37,000 shares; 2025Q4: 188,000 shares; 2026Q1: 140,672 shares; 2026Q2: 1,288,053 shares 1,288,053 $47.8M 2.25% +1,147,381 Timeline CRNX CRINETICS PHARMACEUTICALS IN More: the full row for CRINETICS PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 88,425 shares; 2024Q4: 53,125 shares; 2025Q1: 53,125 shares; 2025Q2: 53,125 shares; 2025Q3: 248,368 shares; 2025Q4: 309,368 shares; 2026Q1: 1,139,331 shares; 2026Q2: 1,222,080 shares 1,222,080 $45.7M 2.15% +82,749 Timeline BOXX EA SERIES TRUST More: the full row for EA SERIES TRUST Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 323,382 shares; 2024Q4: 325,450 shares; 2025Q1: 337,125 shares; 2025Q2: 337,125 shares; 2025Q3: 337,125 shares; 2025Q4: 337,125 shares; 2026Q1: 337,125 shares; 2026Q2: 337,125 shares 337,125 $39.5M 1.86% 0 Timeline CYTK CYTOKINETICS INC More: the full row for CYTOKINETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 911,182 shares; 2024Q4: 414,209 shares; 2025Q1: 390,729 shares; 2025Q2: 582,147 shares; 2025Q3: 518,921 shares; 2025Q4: 540,166 shares; 2026Q1: 632,556 shares; 2026Q2: 457,907 shares 457,907 $39M 1.83% -174,649 Timeline SEPN SEPTERNA INC More: the full row for SEPTERNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 720,848 shares; 2025Q2: 847,227 shares; 2025Q3: 1,176,491 shares; 2025Q4: 1,157,611 shares; 2026Q1: 1,089,818 shares; 2026Q2: 940,747 shares 940,747 $31.5M 1.48% -149,071 Timeline AVR ANTERIS TECHNOLOGIES GLOBAL More: the full row for ANTERIS TECHNOLOGIES GLOBAL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 1,052,968 shares; 2025Q1: 1,678,063 shares; 2025Q2: 531,515 shares; 2025Q3: 197,615 shares; 2025Q4: 1,238,777 shares; 2026Q1: 3,789,132 shares; 2026Q2: 3,145,096 shares 3,145,096 $31M 1.46% -644,036 Timeline EDIT EDITAS MEDICINE INC More: the full row for EDITAS MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 8,889,000 shares 8,889,000 $28.8M 1.35% new Timeline DNLI DENALI THERAPEUTICS INC More: the full row for DENALI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 101,826 shares; 2024Q4: 44,826 shares; 2025Q1: 13,873 shares; 2025Q2: 35,716 shares; 2025Q3: 51,516 shares; 2025Q4: 52,116 shares; 2026Q1: 1,871,455 shares; 2026Q2: 1,029,080 shares 1,029,080 $26.5M 1.24% -842,375 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 12,560 shares; 2024Q4: not reported; 2025Q1: 15,033 shares; 2025Q2: 34,051 shares; 2025Q3: 34,051 shares; 2025Q4: 34,051 shares; 2026Q1: 338,323 shares; 2026Q2: 283,982 shares 283,982 $25.2M 1.19% -54,341 Timeline VIR VIR BIOTECHNOLOGY INC More: the full row for VIR BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 319,185 shares; 2024Q4: 64,067 shares; 2025Q1: 250,000 shares; 2025Q2: 250,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,744,714 shares; 2026Q2: 2,456,677 shares 2,456,677 $25M 1.18% -288,037 Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,500 shares; 2026Q1: 1,500 shares; 2026Q2: 74,253 shares 74,253 $24.9M 1.17% +72,753 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,634 shares; 2024Q4: 21,974 shares; 2025Q1: 6,074 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,392 shares; 2026Q2: 228,520 shares 228,520 $24.4M 1.15% +193,128 Timeline CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,000 shares; 2024Q4: not reported; 2025Q1: 14,600 shares; 2025Q2: 57,466 shares; 2025Q3: 109,442 shares; 2025Q4: 646,767 shares; 2026Q1: 427,816 shares; 2026Q2: 619,542 shares 619,542 $23.1M 1.08% +191,726 Timeline VKTX VIKING THERAPEUTICS INC More: the full row for VIKING THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,100 shares; 2024Q4: 9,300 shares; 2025Q1: 59,413 shares; 2025Q2: 67,813 shares; 2025Q3: 175,919 shares; 2025Q4: 26,494 shares; 2026Q1: 227,717 shares; 2026Q2: 574,038 shares 574,038 $22.4M 1.05% +346,321 Timeline TSHA TAYSHA GENE THERAPIES INC More: the full row for TAYSHA GENE THERAPIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 251,400 shares; 2024Q4: 177,707 shares; 2025Q1: 1,066,309 shares; 2025Q2: 3,009,870 shares; 2025Q3: 2,835,680 shares; 2025Q4: 2,495,809 shares; 2026Q1: 2,979,429 shares; 2026Q2: 3,040,466 shares 3,040,466 $20.7M 0.97% +61,037 Timeline MNPR MONOPAR THERAPEUTICS INC More: the full row for MONOPAR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 130,037 shares; 2025Q1: 100,774 shares; 2025Q2: 100,974 shares; 2025Q3: 129,999 shares; 2025Q4: 233,908 shares; 2026Q1: 264,278 shares; 2026Q2: 217,595 shares 217,595 $20.1M 0.95% -46,683 Timeline OVID OVID THERAPEUTICS INC More: the full row for OVID THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 37,743 shares; 2024Q4: 130,532 shares; 2025Q1: 115,867 shares; 2025Q2: 115,867 shares; 2025Q3: 12,846 shares; 2025Q4: 4,285,000 shares; 2026Q1: 4,544,113 shares; 2026Q2: 7,417,479 shares 7,417,479 $20M 0.94% +2,873,366 Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 329,540 shares; 2026Q2: 387,718 shares 387,718 $19.7M 0.92% +58,178 Timeline ENTA ENANTA PHARMACEUTICALS INC More: the full row for ENANTA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 41,357 shares; 2026Q1: 51,357 shares; 2026Q2: 1,344,510 shares 1,344,510 $19.6M 0.92% +1,293,153 Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,796 shares; 2025Q3: 72,007 shares; 2025Q4: 72,031 shares; 2026Q1: 161,252 shares; 2026Q2: 244,184 shares 244,184 $17M 0.8% +82,932 Timeline INSP INSPIRE MED SYS INC More: the full row for INSPIRE MED SYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,000 shares; 2025Q4: 15,000 shares; 2026Q1: 405,197 shares; 2026Q2: 374,617 shares 374,617 $16.7M 0.79% -30,580 Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 44,351 shares; 2024Q4: 170,000 shares; 2025Q1: 177,136 shares; 2025Q2: 134,136 shares; 2025Q3: 139,136 shares; 2025Q4: 145,079 shares; 2026Q1: 133,893 shares; 2026Q2: 87,509 shares 87,509 $16.4M 0.77% -46,384 Timeline ESTA ESTABLISHMENT LABS HLDGS INC More: the full row for ESTABLISHMENT LABS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,000 shares; 2024Q4: not reported; 2025Q1: 8,000 shares; 2025Q2: 25,000 shares; 2025Q3: 90,688 shares; 2025Q4: 171,422 shares; 2026Q1: 213,473 shares; 2026Q2: 185,619 shares 185,619 $15.9M 0.75% -27,854 Timeline PRTA PROTHENA CORP PLC More: the full row for PROTHENA CORP PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,375,009 shares; 2025Q3: 1,469,098 shares; 2025Q4: 1,457,764 shares; 2026Q1: 1,581,443 shares; 2026Q2: 1,554,535 shares 1,554,535 $15.2M 0.72% -26,908 Timeline RYTM RHYTHM PHARMACEUTICALS INC More: the full row for RHYTHM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 30,941 shares; 2025Q1: 36,890 shares; 2025Q2: 45,390 shares; 2025Q3: 49,571 shares; 2025Q4: 51,349 shares; 2026Q1: 211,450 shares; 2026Q2: 136,158 shares 136,158 $15.1M 0.71% -75,292 Timeline IKT INHIBIKASE THERAPEUTICS INC More: the full row for INHIBIKASE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 5,103,005 shares; 2025Q1: 5,122,105 shares; 2025Q2: 5,122,105 shares; 2025Q3: 5,247,603 shares; 2025Q4: 8,063,949 shares; 2026Q1: 6,606,572 shares; 2026Q2: 7,387,205 shares 7,387,205 $15M 0.7% +780,633 Timeline QURE UNIQURE NV More: the full row for UNIQURE NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 10,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 133,316 shares; 2025Q4: 235,155 shares; 2026Q1: 76,206 shares; 2026Q2: 324,672 shares 324,672 $15M 0.7% +248,466 Timeline RLYB RALLYBIO CORP More: the full row for RALLYBIO CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,535 shares; 2026Q2: 926,352 shares 926,352 $14.8M 0.7% +905,817 Timeline REGN REGENERON PHARMACEUTICALS More: the full row for REGENERON PHARMACEUTICALS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 871 shares; 2024Q4: 1,361 shares; 2025Q1: 1,361 shares; 2025Q2: 3,361 shares; 2025Q3: 15,700 shares; 2025Q4: 12,051 shares; 2026Q1: 12,154 shares; 2026Q2: 22,208 shares 22,208 $13.8M 0.65% +10,054 Timeline IVA INVENTIVA SA More: the full row for INVENTIVA SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,709,846 shares; 2026Q1: 2,174,398 shares; 2026Q2: 3,606,656 shares 3,606,656 $13.6M 0.64% +1,432,258 Timeline STRO SUTRO BIOPHARMA INC More: the full row for SUTRO BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 67,077 shares; 2026Q1: 524,441 shares; 2026Q2: 404,014 shares 404,014 $13.4M 0.63% -120,427 Timeline IONS IONIS PHARMACEUTICALS INC More: the full row for IONIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 700 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 148,461 shares; 2025Q3: 133,818 shares; 2025Q4: 147,130 shares; 2026Q1: 160,338 shares; 2026Q2: 166,286 shares 166,286 $13.2M 0.62% +5,948 Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,448,470 shares; 2024Q4: 678,857 shares; 2025Q1: 339,635 shares; 2025Q2: 259,659 shares; 2025Q3: 273,414 shares; 2025Q4: 213,414 shares; 2026Q1: 94,292 shares; 2026Q2: 176,689 shares 176,689 $13.2M 0.62% +82,397 Timeline SRPT SAREPTA THERAPEUTICS INC More: the full row for SAREPTA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,100 shares; 2024Q4: 40,002 shares; 2025Q1: 122,921 shares; 2025Q2: 210,313 shares; 2025Q3: 349,807 shares; 2025Q4: 28,866 shares; 2026Q1: 262,058 shares; 2026Q2: 730,649 shares 730,649 $13.1M 0.62% +468,591 Timeline CTMX CYTOMX THERAPEUTICS INC. More: the full row for CYTOMX THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 903,959 shares; 2024Q4: 145,036 shares; 2025Q1: 47,036 shares; 2025Q2: 3,081,414 shares; 2025Q3: 4,045,414 shares; 2025Q4: 4,182,769 shares; 2026Q1: 3,410,190 shares; 2026Q2: 3,365,118 shares 3,365,118 $12.6M 0.59% -45,072 Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 680,626 shares 680,626 $12.5M 0.59% new Timeline BIL SPDR SERIES TRUST More: the full row for SPDR SERIES TRUST Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 21,786 shares; 2024Q4: 131,786 shares; 2025Q1: 135,585 shares; 2025Q2: 135,585 shares; 2025Q3: 135,585 shares; 2025Q4: 135,585 shares; 2026Q1: 135,585 shares; 2026Q2: 135,585 shares 135,585 $12.4M 0.58% 0 Timeline EQ EQUILLIUM INC More: the full row for EQUILLIUM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,318 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 5,559,988 shares; 2025Q4: 5,608,078 shares; 2026Q1: 3,726,659 shares; 2026Q2: 3,758,569 shares 3,758,569 $12M 0.57% +31,910 Timeline ANL ADLAI NORTYE GROUP LTD More: the full row for ADLAI NORTYE GROUP LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 117,909 shares; 2026Q2: 1,017,805 shares 1,017,805 $11.7M 0.55% +899,896 Timeline CLYM CLIMB BIO INC More: the full row for CLIMB BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 163,443 shares; 2024Q4: 48,125 shares; 2025Q1: 119,320 shares; 2025Q2: 119,320 shares; 2025Q3: 133,530 shares; 2025Q4: 1,432,475 shares; 2026Q1: 597,662 shares; 2026Q2: 822,649 shares 822,649 $10.7M 0.5% +224,987 Timeline HLXC HELIX ACQUISITION CORP III More: the full row for HELIX ACQUISITION CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares 1,000,000 $10.6M 0.5% 0 Timeline ZURA ZURA BIO LTD More: the full row for ZURA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,770,649 shares; 2024Q4: 2,077,251 shares; 2025Q1: 2,801,184 shares; 2025Q2: 997,547 shares; 2025Q3: 652,154 shares; 2025Q4: 562,065 shares; 2026Q1: 630,403 shares; 2026Q2: 1,759,295 shares 1,759,295 $10.4M 0.49% +1,128,892 Timeline OKUR ONKURE THERAPEUTICS INC More: the full row for ONKURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: not reported; 2025Q4: 1,014,158 shares; 2026Q1: 2,434,941 shares; 2026Q2: 2,238,684 shares 2,238,684 $10.2M 0.48% -196,257 Timeline MAZE MAZE THERAPEUTICS INC More: the full row for MAZE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 26,045 shares; 2025Q4: 179,532 shares; 2026Q1: 50,095 shares; 2026Q2: 339,276 shares 339,276 $10.1M 0.48% +289,181 Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 27,903 shares; 2024Q4: 50,547 shares; 2025Q1: 127,548 shares; 2025Q2: 259,503 shares; 2025Q3: 189,098 shares; 2025Q4: 203,969 shares; 2026Q1: 228,899 shares; 2026Q2: 166,550 shares 166,550 $10.1M 0.47% -62,349 Timeline TEVA TEVA PHARMACEUTICAL INDS LTD More: the full row for TEVA PHARMACEUTICAL INDS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 108,171 shares; 2024Q4: 146,671 shares; 2025Q1: 523,767 shares; 2025Q2: 345,878 shares; 2025Q3: 267,816 shares; 2025Q4: 235,971 shares; 2026Q1: 268,391 shares; 2026Q2: 277,848 shares 277,848 $9.41M 0.44% +9,457 Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 35,000 shares; 2025Q4: 125,375 shares; 2026Q1: 395,459 shares; 2026Q2: 252,395 shares 252,395 $9.29M 0.44% -143,064 Timeline FTH FAETH THERAPEUTICS INC More: the full row for FAETH THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 361,010 shares 361,010 $9.03M 0.42% new Timeline AMLX AMYLYX PHARMACEUTICALS INC More: the full row for AMYLYX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 220,906 shares; 2024Q4: not reported; 2025Q1: 1,471,587 shares; 2025Q2: 1,205,101 shares; 2025Q3: 866,202 shares; 2025Q4: 890,356 shares; 2026Q1: 1,000,604 shares; 2026Q2: 494,378 shares 494,378 $8.88M 0.42% -506,226 Timeline DBVT DBV TECHNOLOGIES S A More: the full row for DBV TECHNOLOGIES S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,012,866 shares; 2026Q2: 528,295 shares 528,295 $8.66M 0.41% -484,571 Timeline SVRA SAVARA INC More: the full row for SAVARA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 742,634 shares; 2024Q4: 988,468 shares; 2025Q1: 1,360,291 shares; 2025Q2: 3,600,670 shares; 2025Q3: 1,988,288 shares; 2025Q4: 1,405,452 shares; 2026Q1: 1,464,535 shares; 2026Q2: 1,403,409 shares 1,403,409 $8.64M 0.41% -61,126 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,097 shares; 2024Q4: not reported; 2025Q1: 12,800 shares; 2025Q2: 98,032 shares; 2025Q3: 213,064 shares; 2025Q4: 315,642 shares; 2026Q1: 259,137 shares; 2026Q2: 146,034 shares 146,034 $8.49M 0.4% -113,103 Timeline CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 143,104 shares; 2024Q4: 215,750 shares; 2025Q1: 301,134 shares; 2025Q2: 523,216 shares; 2025Q3: 248,917 shares; 2025Q4: 258,139 shares; 2026Q1: 185,699 shares; 2026Q2: 118,664 shares 118,664 $8.43M 0.4% -67,035 Timeline MLYS MINERALYS THERAPEUTICS INC More: the full row for MINERALYS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 729,401 shares; 2024Q4: 841,541 shares; 2025Q1: 263,425 shares; 2025Q2: 302,125 shares; 2025Q3: 78,238 shares; 2025Q4: 136,231 shares; 2026Q1: 154,686 shares; 2026Q2: 298,886 shares 298,886 $8.06M 0.38% +144,200 Timeline ASND ASCENDIS PHARMA A/S More: the full row for ASCENDIS PHARMA A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 28,604 shares 28,604 $7.63M 0.36% new Timeline AMAN AMANAT ACQUISITION CORP More: the full row for AMANAT ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 750,000 shares 750,000 $7.62M 0.36% new Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 11,000 shares; 2025Q1: 21,200 shares; 2025Q2: 31,200 shares; 2025Q3: 31,200 shares; 2025Q4: 72,070 shares; 2026Q1: 56,070 shares; 2026Q2: 313,236 shares 313,236 $7.6M 0.36% +257,166 Timeline BHVN BIOHAVEN LTD More: the full row for BIOHAVEN LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,637 shares; 2024Q4: not reported; 2025Q1: 22,641 shares; 2025Q2: 32,341 shares; 2025Q3: 24,341 shares; 2025Q4: 34,277 shares; 2026Q1: 44,777 shares; 2026Q2: 501,687 shares 501,687 $7.47M 0.35% +456,910 Timeline PRME PRIME MEDICINE INC More: the full row for PRIME MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,973,282 shares; 2026Q2: 1,997,552 shares 1,997,552 $7.37M 0.35% +24,270 Timeline FRNM PERCEPTIVE CAP SOLUTIONS COR More: the full row for PERCEPTIVE CAP SOLUTIONS COR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 750,000 shares; 2024Q4: 750,000 shares; 2025Q1: 750,000 shares; 2025Q2: 750,000 shares; 2025Q3: 750,000 shares; 2025Q4: 456,720 shares; 2026Q1: 499,581 shares; 2026Q2: 674,695 shares 674,695 $7.34M 0.35% +175,114 Timeline IRD OPUS GENETICS INC More: the full row for OPUS GENETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 40,000 shares; 2026Q1: 1,849,004 shares; 2026Q2: 1,783,781 shares 1,783,781 $7.33M 0.34% -65,223 Timeline LXEO LEXEO THERAPEUTICS INC More: the full row for LEXEO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 57,166 shares; 2024Q4: 169,505 shares; 2025Q1: 170,448 shares; 2025Q2: 145,109 shares; 2025Q3: 1,531,953 shares; 2025Q4: 1,393,161 shares; 2026Q1: 1,467,350 shares; 2026Q2: 1,565,950 shares 1,565,950 $7.29M 0.34% +98,600 Timeline DMRA DAMORA THERAPEUTICS INC More: the full row for DAMORA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 279,000 shares; 2026Q2: 280,000 shares 280,000 $7.28M 0.34% +1,000 Timeline REPL REPLIMUNE GROUP INC More: the full row for REPLIMUNE GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,400 shares; 2025Q3: 978,894 shares; 2025Q4: 1,241,322 shares; 2026Q1: 1,582,987 shares; 2026Q2: 655,784 shares 655,784 $7.26M 0.34% -927,203 Timeline LONA LEONABIO INC More: the full row for LEONABIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 393,701 shares; 2026Q1: 727,481 shares; 2026Q2: 777,100 shares 777,100 $7.14M 0.34% +49,619 Timeline KRRO KORRO BIO INC More: the full row for KORRO BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 49,451 shares; 2024Q4: 57,978 shares; 2025Q1: 68,715 shares; 2025Q2: 68,815 shares; 2025Q3: 40,235 shares; 2025Q4: not reported; 2026Q1: 540,054 shares; 2026Q2: 540,054 shares 540,054 $7.12M 0.33% 0 Timeline RACC RESEARCH ALLIANCE CORP III More: the full row for RESEARCH ALLIANCE CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 650,000 shares 650,000 $6.96M 0.33% new Timeline IFRX INFLARX NV More: the full row for INFLARX NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 159,479 shares; 2025Q4: not reported; 2026Q1: 158,271 shares; 2026Q2: 3,000,000 shares 3,000,000 $6.72M 0.32% +2,841,729 Timeline RLAY RELAY THERAPEUTICS INC More: the full row for RELAY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 358,333 shares 358,333 $6.7M 0.32% new Timeline JANX JANUX THERAPEUTICS INC More: the full row for JANUX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 13,000 shares; 2024Q4: 31,509 shares; 2025Q1: 153,767 shares; 2025Q2: 62,088 shares; 2025Q3: 351,032 shares; 2025Q4: 245,452 shares; 2026Q1: 298,546 shares; 2026Q2: 420,881 shares 420,881 $6.46M 0.3% +122,335 Timeline PLRX PLIANT THERAPEUTICS INC More: the full row for PLIANT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 246,128 shares; 2024Q4: 134,798 shares; 2025Q1: not reported; 2025Q2: 82,189 shares; 2025Q3: not reported; 2025Q4: 73,819 shares; 2026Q1: 2,585,126 shares; 2026Q2: 5,509,724 shares 5,509,724 $6.28M 0.3% +2,924,598 Timeline WHWK WHITEHAWK THERAPEUTICS INC More: the full row for WHITEHAWK THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 77,593 shares; 2026Q1: 128,503 shares; 2026Q2: 1,341,394 shares 1,341,394 $6.14M 0.29% +1,212,891 Timeline KRYS KRYSTAL BIOTECH INC More: the full row for KRYSTAL BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 100 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,523 shares; 2025Q4: 20,014 shares; 2026Q1: 20,014 shares; 2026Q2: 16,420 shares 16,420 $6.1M 0.29% -3,594 Timeline ABUS ARBUTUS BIOPHARMA CORP More: the full row for ARBUTUS BIOPHARMA CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,089,321 shares; 2024Q4: 1,554,802 shares; 2025Q1: 1,879,114 shares; 2025Q2: 2,825,773 shares; 2025Q3: 2,903,226 shares; 2025Q4: 5,415,109 shares; 2026Q1: 3,133,175 shares; 2026Q2: 1,268,147 shares 1,268,147 $6.09M 0.29% -1,865,028 Timeline PFE PFIZER INC More: the full row for PFIZER INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 35,950 shares; 2024Q4: 35,050 shares; 2025Q1: 41,050 shares; 2025Q2: 39,400 shares; 2025Q3: 44,400 shares; 2025Q4: 72,400 shares; 2026Q1: 77,400 shares; 2026Q2: 252,400 shares 252,400 $6.08M 0.29% +175,000 Timeline BHF BRIGHTHOUSE FINL INC More: the full row for BRIGHTHOUSE FINL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 95,523 shares; 2026Q1: 95,523 shares; 2026Q2: 95,523 shares 95,523 $6.05M 0.28% 0 Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 18,178 shares; 2024Q4: not reported; 2025Q1: 20,000 shares; 2025Q2: 40,000 shares; 2025Q3: 40,000 shares; 2025Q4: 90,999 shares; 2026Q1: 90,599 shares; 2026Q2: 143,199 shares 143,199 $5.82M 0.27% +52,600 Timeline ALEC ALECTOR INC More: the full row for ALECTOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 428,802 shares; 2024Q4: 368,330 shares; 2025Q1: 380,330 shares; 2025Q2: 1,723,526 shares; 2025Q3: not reported; 2025Q4: 1,108,000 shares; 2026Q1: 1,050,000 shares; 2026Q2: 2,883,583 shares 2,883,583 $5.8M 0.27% +1,833,583 Timeline FULC FULCRUM THERAPEUTICS INC More: the full row for FULCRUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 55,802 shares; 2024Q4: 196,248 shares; 2025Q1: 490,532 shares; 2025Q2: 53,349 shares; 2025Q3: 341,612 shares; 2025Q4: 1,253,749 shares; 2026Q1: 130,560 shares; 2026Q2: 1,565,029 shares 1,565,029 $5.73M 0.27% +1,434,469 Timeline ARWR ARROWHEAD PHARMACEUTICALS IN More: the full row for ARROWHEAD PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 11,705 shares; 2024Q4: 12,900 shares; 2025Q1: 56,300 shares; 2025Q2: 55,200 shares; 2025Q3: 49,800 shares; 2025Q4: 58,200 shares; 2026Q1: 70,300 shares; 2026Q2: 69,800 shares 69,800 $5.69M 0.27% -500 Timeline ABOS ACUMEN PHARMACEUTICALS INC More: the full row for ACUMEN PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 94,294 shares; 2025Q1: 146,183 shares; 2025Q2: 916,183 shares; 2025Q3: 891,183 shares; 2025Q4: 891,183 shares; 2026Q1: 2,156,334 shares; 2026Q2: 2,111,334 shares 2,111,334 $5.64M 0.26% -45,000 Timeline OACCU OAKTREE ACQUISITION CORP III More: the full row for OAKTREE ACQUISITION CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 500,000 shares; 2025Q1: 516,482 shares; 2025Q2: 516,482 shares; 2025Q3: 516,482 shares; 2025Q4: 516,482 shares; 2026Q1: 516,482 shares; 2026Q2: 516,482 shares 516,482 $5.6M 0.26% 0 Timeline GMED GLOBUS MED INC More: the full row for GLOBUS MED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,100 shares; 2026Q1: 20,100 shares; 2026Q2: 70,100 shares 70,100 $5.54M 0.26% +50,000 Timeline GLUE MONTE ROSA THERAPEUTICS INC More: the full row for MONTE ROSA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 215,752 shares; 2025Q4: 215,752 shares; 2026Q1: 215,752 shares; 2026Q2: 216,752 shares 216,752 $5.25M 0.25% +1,000 Timeline DGACU DISCIPLINED GROWTH ACQUIS CO More: the full row for DISCIPLINED GROWTH ACQUIS CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 500,000 shares 500,000 $5.02M 0.24% new Timeline BHAVU BHAV ACQUISITION CORP More: the full row for BHAV ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 495,000 shares; 2026Q2: 495,000 shares 495,000 $5M 0.24% 0 Timeline DHR DANAHER CORP DEL More: the full row for DANAHER CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 4,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,600 shares; 2026Q1: 30,932 shares; 2026Q2: 25,932 shares 25,932 $4.94M 0.23% -5,000 Timeline BOLD BOUNDLESS BIO INC More: the full row for BOUNDLESS BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,968,216 shares 1,968,216 $4.92M 0.23% new Timeline AVLN AVALYN PHARMACEUTICALS INC More: the full row for AVALYN PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 146,447 shares 146,447 $4.82M 0.23% new Timeline SPRY ARS PHARMACEUTICALS INC More: the full row for ARS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 59,230 shares; 2025Q4: 369,569 shares; 2026Q1: 1,361,536 shares; 2026Q2: 600,999 shares 600,999 $4.81M 0.23% -760,537 Timeline ATAI ATAIBECKLEY INC More: the full row for ATAIBECKLEY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 913,242 shares; 2026Q2: 913,242 shares 913,242 $4.81M 0.23% 0 Timeline PRLD PRELUDE THERAPEUTICS INC More: the full row for PRELUDE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 152,825 shares; 2026Q2: 900,900 shares 900,900 $4.8M 0.23% +748,075 Timeline JATT JATT II ACQUISITION CORP More: the full row for JATT II ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 417,724 shares 417,724 $4.75M 0.22% new Timeline RNTX REIN THERAPEUTICS INC More: the full row for REIN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,500,000 shares 4,500,000 $4.68M 0.22% new Timeline PEPG PEPGEN INC More: the full row for PEPGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 20,352 shares; 2025Q2: 20,352 shares; 2025Q3: 36,842 shares; 2025Q4: 36,842 shares; 2026Q1: 1,607,638 shares; 2026Q2: 2,591,085 shares 2,591,085 $4.66M 0.22% +983,447 Timeline CTNM CONTINEUM THERAPEUTICS INC More: the full row for CONTINEUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 8,967 shares; 2024Q4: 82,234 shares; 2025Q1: 168,765 shares; 2025Q2: 166,799 shares; 2025Q3: 77,961 shares; 2025Q4: 278,961 shares; 2026Q1: 276,661 shares; 2026Q2: 278,961 shares 278,961 $4.57M 0.21% +2,300 Timeline CATX PERSPECTIVE THERAPEUTICS INC More: the full row for PERSPECTIVE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 95,193 shares; 2026Q1: 749,335 shares; 2026Q2: 1,210,117 shares 1,210,117 $4.13M 0.19% +460,782 Timeline APGE APOGEE THERAPEUTICS INC More: the full row for APOGEE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 57,183 shares; 2024Q4: 41,274 shares; 2025Q1: 104,853 shares; 2025Q2: 18,070 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 31,000 shares 31,000 $4.11M 0.19% new Timeline NAMS NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 112,359 shares; 2025Q3: 114,359 shares; 2025Q4: 118,623 shares; 2026Q1: 118,623 shares; 2026Q2: 118,623 shares 118,623 $4.02M 0.19% 0 Timeline CRBP CORBUS PHARMACEUTICALS HLDGS More: the full row for CORBUS PHARMACEUTICALS HLDGS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,200 shares; 2025Q4: 286,781 shares; 2026Q1: 331,781 shares; 2026Q2: 421,787 shares 421,787 $3.96M 0.19% +90,006 Timeline BIIB BIOGEN INC More: the full row for BIOGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 29,625 shares; 2024Q4: 3,045 shares; 2025Q1: 4,500 shares; 2025Q2: 5,100 shares; 2025Q3: 18,000 shares; 2025Q4: 24,300 shares; 2026Q1: 11,000 shares; 2026Q2: 17,900 shares 17,900 $3.87M 0.18% +6,900 Timeline XNCR XENCOR INC More: the full row for XENCOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 342,262 shares; 2024Q4: 234,607 shares; 2025Q1: 398,152 shares; 2025Q2: 85,826 shares; 2025Q3: 128,865 shares; 2025Q4: 56,165 shares; 2026Q1: 93,665 shares; 2026Q2: 232,560 shares 232,560 $3.74M 0.18% +138,895 Timeline SLN SILENCE THERAPEUTICS PLC More: the full row for SILENCE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 40,290 shares; 2024Q4: 18,000 shares; 2025Q1: 18,643 shares; 2025Q2: 18,643 shares; 2025Q3: 18,643 shares; 2025Q4: 23,643 shares; 2026Q1: 172,157 shares; 2026Q2: 338,373 shares 338,373 $3.72M 0.17% +166,216 Timeline SPRB SPRUCE BIOSCIENCES INC More: the full row for SPRUCE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 58,000 shares; 2026Q1: 58,600 shares; 2026Q2: 67,717 shares 67,717 $3.66M 0.17% +9,117 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 34,124 shares; 2025Q3: 34,124 shares; 2025Q4: 85,528 shares; 2026Q1: 105,528 shares; 2026Q2: 105,528 shares 105,528 $3.65M 0.17% 0 Timeline ENGN ENGENE THERAPEUTICS INC More: the full row for ENGENE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,104,986 shares 2,104,986 $3.64M 0.17% new Timeline PALI PALISADE BIO INC More: the full row for PALISADE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,004,845 shares; 2026Q1: 2,264,845 shares; 2026Q2: 1,726,662 shares 1,726,662 $3.61M 0.17% -538,183 Timeline TARA PROTARA THERAPEUTICS INC More: the full row for PROTARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 122,690 shares; 2025Q1: 122,690 shares; 2025Q2: 122,690 shares; 2025Q3: 35,223 shares; 2025Q4: 1,136,799 shares; 2026Q1: 940,512 shares; 2026Q2: 940,512 shares 940,512 $3.59M 0.17% 0 Timeline SGMT SAGIMET BIOSCIENCES INC More: the full row for SAGIMET BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 437,500 shares 437,500 $3.38M 0.16% new Timeline ONC BEONE MEDICINES LTD More: the full row for BEONE MEDICINES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 978 shares; 2024Q4: 2,974 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 11,701 shares; 2026Q2: 11,701 shares 11,701 $3.33M 0.16% 0 Timeline IVVD INVIVYD INC More: the full row for INVIVYD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,370,987 shares; 2025Q4: 3,899,397 shares; 2026Q1: 3,822,427 shares; 2026Q2: 3,807,427 shares 3,807,427 $3.32M 0.16% -15,000 Timeline TENX TENAX THERAPEUTICS INC More: the full row for TENAX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 62,423 shares; 2024Q4: 34,693 shares; 2025Q1: 68,741 shares; 2025Q2: 155,557 shares; 2025Q3: 53,428 shares; 2025Q4: 63,673 shares; 2026Q1: 213,462 shares; 2026Q2: 220,462 shares 220,462 $3.21M 0.15% +7,000 Timeline ZNTL ZENTALIS PHARMACEUTICALS INC More: the full row for ZENTALIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,000 shares; 2025Q3: 50,000 shares; 2025Q4: 80,000 shares; 2026Q1: 144,636 shares; 2026Q2: 652,750 shares 652,750 $3.17M 0.15% +508,114 Timeline RLMD RELMADA THERAPEUTICS INC More: the full row for RELMADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 130,000 shares; 2025Q3: not reported; 2025Q4: 30,866 shares; 2026Q1: 451,918 shares; 2026Q2: 451,918 shares 451,918 $3.13M 0.15% 0 Timeline DCTH DELCATH SYS INC More: the full row for DELCATH SYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 31,052 shares; 2024Q4: 149,385 shares; 2025Q1: 149,385 shares; 2025Q2: 149,385 shares; 2025Q3: 224,385 shares; 2025Q4: 224,385 shares; 2026Q1: 224,385 shares; 2026Q2: 224,385 shares 224,385 $2.83M 0.13% 0 Timeline BMRN BIOMARIN PHARMACEUTICAL INC More: the full row for BIOMARIN PHARMACEUTICAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,200 shares; 2024Q4: not reported; 2025Q1: 4,900 shares; 2025Q2: 4,900 shares; 2025Q3: 4,900 shares; 2025Q4: 12,900 shares; 2026Q1: 18,200 shares; 2026Q2: 49,000 shares 49,000 $2.8M 0.13% +30,800 Timeline SMMT SUMMIT THERAPEUTICS INC More: the full row for SUMMIT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 12,000 shares; 2025Q3: 102,969 shares; 2025Q4: 91,869 shares; 2026Q1: 91,869 shares; 2026Q2: 191,869 shares 191,869 $2.8M 0.13% +100,000 Timeline KROS KEROS THERAPEUTICS INC More: the full row for KEROS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 445,068 shares; 2024Q4: 23,246 shares; 2025Q1: 1,486,461 shares; 2025Q2: 5,389,264 shares; 2025Q3: 5,389,264 shares; 2025Q4: 18,851 shares; 2026Q1: 97,318 shares; 2026Q2: 246,818 shares 246,818 $2.64M 0.12% +149,500 Timeline ELDN ELEDON PHARMACEUTICALS INC More: the full row for ELEDON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 16,000 shares; 2025Q1: 16,600 shares; 2025Q2: 16,900 shares; 2025Q3: not reported; 2025Q4: 1,821,812 shares; 2026Q1: 974,421 shares; 2026Q2: 647,812 shares 647,812 $2.55M 0.12% -326,609 Timeline SNY SANOFI SA More: the full row for SANOFI SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 99,600 shares; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 74,212 shares; 2025Q4: 63,474 shares; 2026Q1: 316,939 shares; 2026Q2: 57,100 shares 57,100 $2.44M 0.11% -259,839 Timeline AEXA AMERICAN EXCEPTIONALISM ACQU More: the full row for AMERICAN EXCEPTIONALISM ACQU Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 357,539 shares; 2026Q1: 357,539 shares; 2026Q2: 205,408 shares 205,408 $2.43M 0.11% -152,131 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 41,346 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 140,021 shares; 2026Q1: 50,000 shares; 2026Q2: 76,761 shares 76,761 $2.4M 0.11% +26,761 Timeline ISRG INTUITIVE SURGICAL INC More: the full row for INTUITIVE SURGICAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 700 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,020 shares; 2026Q1: 1,830 shares; 2026Q2: 6,030 shares 6,030 $2.4M 0.11% +4,200 Timeline INO INOVIO PHARMACEUTICALS INC More: the full row for INOVIO PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,485,008 shares; 2026Q1: 1,470,108 shares; 2026Q2: 2,143,910 shares 2,143,910 $2.36M 0.11% +673,802 Timeline OABI OMNIAB INC More: the full row for OMNIAB INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,337,302 shares; 2024Q4: 278,108 shares; 2025Q1: 126,108 shares; 2025Q2: 326,108 shares; 2025Q3: 1,090,628 shares; 2025Q4: 702,190 shares; 2026Q1: 705,190 shares; 2026Q2: 947,412 shares 947,412 $2.33M 0.11% +242,222 Timeline CAPR CAPRICOR THERAPEUTICS INC More: the full row for CAPRICOR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 24,307 shares; 2024Q4: 56,120 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 90,593 shares; 2026Q2: 90,593 shares 90,593 $2.18M 0.1% 0 Timeline DRUG BRIGHT MINDS BIOSCIENCES INC More: the full row for BRIGHT MINDS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,500 shares; 2026Q1: 33,900 shares; 2026Q2: 30,300 shares 30,300 $2.13M 0.1% -3,600 Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 11,187 shares; 2024Q4: not reported; 2025Q1: 132,780 shares; 2025Q2: 142,780 shares; 2025Q3: 20,840 shares; 2025Q4: 20,840 shares; 2026Q1: 20,840 shares; 2026Q2: 20,840 shares 20,840 $1.98M 0.09% 0 Timeline VYNE VYNE THERAPEUTICS INC More: the full row for VYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 152,865 shares; 2024Q4: not reported; 2025Q1: 70,419 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 253,791 shares; 2026Q1: 1,063,899 shares; 2026Q2: 2,950,000 shares 2,950,000 $1.92M 0.09% +1,886,101 Timeline MCK MCKESSON CORP More: the full row for MCKESSON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,850 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,200 shares; 2026Q1: 1,200 shares; 2026Q2: 2,500 shares 2,500 $1.89M 0.09% +1,300 Timeline LXRX LEXICON PHARMACEUTICALS INC More: the full row for LEXICON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 750,000 shares; 2026Q2: 750,000 shares 750,000 $1.8M 0.08% 0 Timeline CRVS CORVUS PHARMACEUTICALS INC More: the full row for CORVUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 465,875 shares; 2026Q1: 87,901 shares; 2026Q2: 117,101 shares 117,101 $1.75M 0.08% +29,200 Timeline CUE CUE BIOPHARMA INC More: the full row for CUE BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 55,193 shares 55,193 $1.74M 0.08% new Timeline MSLE SATELLOS BIOSCIENCE INC More: the full row for SATELLOS BIOSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 222,555 shares; 2026Q2: 222,555 shares 222,555 $1.73M 0.08% 0 Timeline KNSA KINIKSA PHARMACEUTICALS INTL More: the full row for KINIKSA PHARMACEUTICALS INTL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 436,668 shares; 2024Q4: 166,406 shares; 2025Q1: 41,412 shares; 2025Q2: 56,540 shares; 2025Q3: 75,187 shares; 2025Q4: 28,728 shares; 2026Q1: 26,913 shares; 2026Q2: 26,913 shares 26,913 $1.72M 0.08% 0 Timeline CNTB CONNECT BIOPHARMA HLDGS LTD More: the full row for CONNECT BIOPHARMA HLDGS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 742,400 shares; 2026Q2: 700,000 shares 700,000 $1.67M 0.08% -42,400 Timeline CCIIU COHEN CIRCLE ACQUISIT CORP I More: the full row for COHEN CIRCLE ACQUISIT CORP I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 150,000 shares; 2025Q4: 150,000 shares; 2026Q1: 150,000 shares; 2026Q2: 150,000 shares 150,000 $1.58M 0.07% 0 Timeline RCKT ROCKET PHARMACEUTICALS INC More: the full row for ROCKET PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,300 shares; 2024Q4: 211,400 shares; 2025Q1: 241,800 shares; 2025Q2: 275,800 shares; 2025Q3: 575,800 shares; 2025Q4: 475,800 shares; 2026Q1: 432,500 shares; 2026Q2: 435,500 shares 435,500 $1.49M 0.07% +3,000 Timeline TRAX FIRST TRACKS BIOTHERAPEUTICS More: the full row for FIRST TRACKS BIOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 71,910 shares 71,910 $1.45M 0.07% new Timeline EVMN EVOMMUNE INC More: the full row for EVOMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 184,062 shares; 2026Q1: 184,062 shares; 2026Q2: 104,035 shares 104,035 $1.38M 0.06% -80,027 Timeline CCCC C4 THERAPEUTICS INC More: the full row for C4 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 43,000 shares; 2026Q2: 291,957 shares 291,957 $1.36M 0.06% +248,957 Timeline BCRX BIOCRYST PHARMACEUTICALS INC More: the full row for BIOCRYST PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 35,000 shares; 2024Q4: 35,000 shares; 2025Q1: 10,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,000 shares; 2026Q1: 105,000 shares; 2026Q2: 133,000 shares 133,000 $1.33M 0.06% +28,000 Timeline SUPN SUPERNUS PHARMACEUTICALS More: the full row for SUPERNUS PHARMACEUTICALS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,418 shares; 2025Q4: 29,742 shares; 2026Q1: 29,642 shares; 2026Q2: 27,842 shares 27,842 $1.29M 0.06% -1,800 Timeline NVO NOVO-NORDISK A S More: the full row for NOVO-NORDISK A S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 33,000 shares; 2026Q2: 27,000 shares 27,000 $1.29M 0.06% -6,000 Timeline AVTR AVANTOR INC More: the full row for AVANTOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 25,000 shares; 2025Q4: 70,000 shares; 2026Q1: 80,000 shares; 2026Q2: 130,000 shares 130,000 $1.29M 0.06% +50,000 Timeline INM INMED PHARMACEUTICALS INC More: the full row for INMED PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 800,000 shares 800,000 $1.24M 0.06% new 2026-10-08, Form 4 Timeline PMN PROMIS NEUROSCIENCES INC More: the full row for PROMIS NEUROSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 95,350 shares; 2026Q2: 92,850 shares 92,850 $1.22M 0.06% -2,500 Timeline ARTV ARTIVA BIOTHERAPEUTICS INC More: the full row for ARTIVA BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 118,624 shares 118,624 $1.15M 0.05% new Timeline TNYA TENAYA THERAPEUTICS INC More: the full row for TENAYA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,505,300 shares; 2026Q1: 1,507,800 shares; 2026Q2: 1,555,500 shares 1,555,500 $1.15M 0.05% +47,700 Timeline ALXO ALX ONCOLOGY HLDGS INC More: the full row for ALX ONCOLOGY HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 533,660 shares 533,660 $1.1M 0.05% new Timeline ARE ALEXANDRIA REAL ESTATE EQ IN More: the full row for ALEXANDRIA REAL ESTATE EQ IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 16,300 shares; 2026Q1: 19,500 shares; 2026Q2: 19,500 shares 19,500 $1.03M 0.05% 0 Timeline RNAC CARTESIAN THERAPEUTICS INC More: the full row for CARTESIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 98,877 shares 98,877 $1.03M 0.05% new Timeline CYCN CYCLERION THERAPEUTICS INC More: the full row for CYCLERION THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 298,757 shares 298,757 $1.01M 0.05% new Timeline EA ELECTRONIC ARTS INC More: the full row for ELECTRONIC ARTS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,936 shares; 2025Q4: 4,936 shares; 2026Q1: 4,936 shares; 2026Q2: 4,936 shares 4,936 $1.01M 0.05% 0 Timeline BNTX BIONTECH SE More: the full row for BIONTECH SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,000 shares; 2024Q4: not reported; 2025Q1: 5,000 shares; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,600 shares 10,600 $986K 0.05% +600 Timeline ACAD ACADIA PHARMACEUTICALS INC More: the full row for ACADIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 23,100 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 38,955 shares 38,955 $986K 0.05% new Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 400 shares; 2024Q4: not reported; 2025Q1: 30,099 shares; 2025Q2: 23,063 shares; 2025Q3: 37,663 shares; 2025Q4: 42,674 shares; 2026Q1: 47,463 shares; 2026Q2: 42,821 shares 42,821 $951K 0.04% -4,642 Timeline MPLT MAPLIGHT THERAPEUTICS INC More: the full row for MAPLIGHT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 374,909 shares; 2026Q2: 26,497 shares 26,497 $950K 0.04% -348,412 Timeline GPCR STRUCTURE THERAPEUTICS INC More: the full row for STRUCTURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 35,319 shares; 2025Q1: 35,619 shares; 2025Q2: 15,000 shares; 2025Q3: 15,200 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 17,500 shares 17,500 $939K 0.04% new Timeline WVE WAVE LIFE SCIENCES LTD More: the full row for WAVE LIFE SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 21,700 shares; 2025Q1: 23,100 shares; 2025Q2: 114,814 shares; 2025Q3: 119,067 shares; 2025Q4: not reported; 2026Q1: 44,900 shares; 2026Q2: 160,000 shares 160,000 $930K 0.04% +115,100 Timeline AURA AURA BIOSCIENCES INC More: the full row for AURA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 73,663 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 130,152 shares 130,152 $924K 0.04% new Timeline CCXI CHURCHILL CAP CORP XI More: the full row for CHURCHILL CAP CORP XI Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares 50,000 $872K 0.04% new Timeline KZIA KAZIA THERAPEUTICS LTD More: the full row for KAZIA THERAPEUTICS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 61,550 shares 61,550 $867K 0.04% new Timeline NUVL NUVALENT INC More: the full row for NUVALENT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,442 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 11,842 shares; 2025Q3: 11,842 shares; 2025Q4: 6,842 shares; 2026Q1: 6,942 shares; 2026Q2: 6,942 shares 6,942 $857K 0.04% 0 Timeline LRMR LARIMAR THERAPEUTICS INC More: the full row for LARIMAR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 237,605 shares; 2025Q3: 235,689 shares; 2025Q4: 185,689 shares; 2026Q1: 52,745 shares; 2026Q2: 272,745 shares 272,745 $832K 0.04% +220,000 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 14,733 shares; 2026Q1: 16,033 shares; 2026Q2: 18,322 shares 18,322 $786K 0.04% +2,289 Timeline ADGM ADAGIO MED HLDGS INC More: the full row for ADAGIO MED HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 148,861 shares; 2024Q4: 76,757 shares; 2025Q1: 76,757 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,159,614 shares; 2026Q1: 1,205,447 shares; 2026Q2: 1,205,447 shares 1,205,447 $785K 0.04% 0 Timeline RNA ATRIUM THERAPEUTICS INC More: the full row for ATRIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 57,688 shares; 2026Q2: 57,688 shares 57,688 $776K 0.04% 0 Timeline TXMD THERAPEUTICSMD INC More: the full row for THERAPEUTICSMD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 270,160 shares; 2024Q4: 270,160 shares; 2025Q1: 270,160 shares; 2025Q2: 209,210 shares; 2025Q3: 209,210 shares; 2025Q4: 209,210 shares; 2026Q1: 209,210 shares; 2026Q2: 342,447 shares 342,447 $757K 0.04% +133,237 Timeline IDYA IDEAYA BIOSCIENCES INC More: the full row for IDEAYA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares 20,000 $745K 0.04% 0 Timeline SIBN SI BONE INC More: the full row for SI BONE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 12,580 shares; 2026Q2: 45,000 shares 45,000 $734K 0.03% +32,420 Timeline RPRX ROYALTY PHARMA PLC More: the full row for ROYALTY PHARMA PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,096,666 shares; 2024Q4: 49,963 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,000 shares; 2026Q2: 12,500 shares 12,500 $701K 0.03% +7,500 Timeline EOLS EVOLUS INC More: the full row for EVOLUS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,859 shares; 2026Q1: 55,859 shares; 2026Q2: 100,000 shares 100,000 $694K 0.03% +44,141 Timeline IBIO IBIO INC More: the full row for IBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 476,212 shares; 2024Q4: 415,606 shares; 2025Q1: not reported; 2025Q2: 54,819 shares; 2025Q3: 27,000 shares; 2025Q4: 405,531 shares; 2026Q1: 469,878 shares; 2026Q2: 375,531 shares 375,531 $657K 0.03% -94,347 Timeline FWRD FORWARD AIR CORP More: the full row for FORWARD AIR CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 26,635 shares; 2026Q1: 78,241 shares; 2026Q2: 48,241 shares 48,241 $652K 0.03% -30,000 Timeline GERN GERON CORP More: the full row for GERON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 557,159 shares; 2024Q4: 337,676 shares; 2025Q1: 266,176 shares; 2025Q2: 441,176 shares; 2025Q3: 456,176 shares; 2025Q4: 336,176 shares; 2026Q1: 200,000 shares; 2026Q2: 505,817 shares 505,817 $647K 0.03% +305,817 Timeline SYK STRYKER CORPORATION More: the full row for STRYKER CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,000 shares 2,000 $630K 0.03% new Timeline IOVA IOVANCE BIOTHERAPEUTICS INC More: the full row for IOVANCE BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,700 shares; 2024Q4: 15,700 shares; 2025Q1: 15,700 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 146,090 shares 146,090 $608K 0.03% new Timeline MGNX MACROGENICS INC More: the full row for MACROGENICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,000 shares; 2026Q2: 129,822 shares 129,822 $600K 0.03% +89,822 Timeline GILD GILEAD SCIENCES INC More: the full row for GILEAD SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 6,666 shares; 2026Q1: 6,351 shares; 2026Q2: 4,648 shares 4,648 $587K 0.03% -1,703 Timeline NTRA NATERA INC More: the full row for NATERA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 4,250 shares; 2025Q2: 2,500 shares; 2025Q3: not reported; 2025Q4: 2,147 shares; 2026Q1: 2,147 shares; 2026Q2: 2,147 shares 2,147 $583K 0.03% 0 Timeline SPTX SEAPORT THERAPEUTICS INC More: the full row for SEAPORT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 26,000 shares 26,000 $565K 0.03% new Timeline ASMB ASSEMBLY BIOSCIENCES INC More: the full row for ASSEMBLY BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,947 shares; 2025Q4: 19,747 shares; 2026Q1: 19,947 shares; 2026Q2: 20,447 shares 20,447 $562K 0.03% +500 Timeline HELP CYBIN INC More: the full row for CYBIN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 33,278 shares; 2025Q4: 238,390 shares; 2026Q1: 31,278 shares; 2026Q2: 81,278 shares 81,278 $537K 0.03% +50,000 Timeline BNTC BENITEC BIOPHARMA INC More: the full row for BENITEC BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 17,500 shares; 2026Q2: 40,000 shares 40,000 $535K 0.03% +22,500 Timeline PYPD POLYPID LTD More: the full row for POLYPID LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 93,902 shares; 2024Q4: 80,080 shares; 2025Q1: 80,080 shares; 2025Q2: 103,950 shares; 2025Q3: not reported; 2025Q4: 103,950 shares; 2026Q1: 103,950 shares; 2026Q2: 103,950 shares 103,950 $528K 0.02% 0 Timeline LUNG PULMONX CORP More: the full row for PULMONX CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 28,221 shares; 2025Q1: not reported; 2025Q2: 204,497 shares; 2025Q3: 214,497 shares; 2025Q4: 355,410 shares; 2026Q1: 374,497 shares; 2026Q2: 404,497 shares 404,497 $526K 0.02% +30,000 Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 23,457 shares; 2024Q4: 17,424 shares; 2025Q1: 5,424 shares; 2025Q2: 34,314 shares; 2025Q3: 151,495 shares; 2025Q4: not reported; 2026Q1: 457,137 shares; 2026Q2: 27,000 shares 27,000 $526K 0.02% -430,137 Timeline GLOBA TERRA ACQUISITION COR GLOBA TERRA ACQUISITION COR More: the full row for GLOBA TERRA ACQUISITION COR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 50,000 shares; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares 50,000 $520K 0.02% 0 TRAW TRAWS PHARMA INC More: the full row for TRAWS PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 154,431 shares; 2026Q1: 154,098 shares; 2026Q2: 597,729 shares 597,729 $504K 0.02% +443,631 Timeline USFR WISDOMTREE TR More: the full row for WISDOMTREE TR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,000 shares; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares 10,000 $504K 0.02% 0 Timeline TECX TECTONIC THERAPEUTIC INC More: the full row for TECTONIC THERAPEUTIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 127,159 shares; 2024Q4: 58,708 shares; 2025Q1: 62,603 shares; 2025Q2: 73,505 shares; 2025Q3: 56,007 shares; 2025Q4: 30,007 shares; 2026Q1: 13,001 shares; 2026Q2: 14,501 shares 14,501 $498K 0.02% +1,500 Timeline MDGL MADRIGAL PHARMACEUTICALS INC More: the full row for MADRIGAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 50 shares; 2024Q4: not reported; 2025Q1: 1,490 shares; 2025Q2: 1,054 shares; 2025Q3: 4,895 shares; 2025Q4: 895 shares; 2026Q1: 895 shares; 2026Q2: 895 shares 895 $481K 0.02% 0 Timeline ARVN ARVINAS INC More: the full row for ARVINAS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 20,400 shares; 2024Q4: not reported; 2025Q1: 313,354 shares; 2025Q2: 128,767 shares; 2025Q3: 82,591 shares; 2025Q4: 58,091 shares; 2026Q1: 57,591 shares; 2026Q2: 57,591 shares 57,591 $479K 0.02% 0 Timeline KIDS ORTHOPEDIATRICS CORP More: the full row for ORTHOPEDIATRICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 19,845 shares; 2026Q1: 19,845 shares; 2026Q2: 25,000 shares 25,000 $478K 0.02% +5,155 Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 12,200 shares 12,200 $472K 0.02% new Timeline PHAT PHATHOM PHARMACEUTICALS INC More: the full row for PHATHOM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 200 shares; 2024Q4: 55,400 shares; 2025Q1: 42,800 shares; 2025Q2: 63,424 shares; 2025Q3: 42,900 shares; 2025Q4: 42,900 shares; 2026Q1: 42,900 shares; 2026Q2: 42,900 shares 42,900 $465K 0.02% 0 Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 24,100 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,200 shares; 2026Q2: 3,900 shares 3,900 $457K 0.02% -2,300 Timeline KPRX KIORA PHARMACEUTICALS INC More: the full row for KIORA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 196,551 shares; 2024Q4: 200,221 shares; 2025Q1: 194,665 shares; 2025Q2: 167,111 shares; 2025Q3: 167,941 shares; 2025Q4: 167,941 shares; 2026Q1: 167,941 shares; 2026Q2: 167,941 shares 167,941 $442K 0.02% 0 Timeline KURA KURA ONCOLOGY INC More: the full row for KURA ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 30,000 shares; 2024Q4: not reported; 2025Q1: 25,000 shares; 2025Q2: 34,300 shares; 2025Q3: 55,000 shares; 2025Q4: 40,000 shares; 2026Q1: 40,000 shares; 2026Q2: 40,000 shares 40,000 $439K 0.02% 0 Timeline CNTX CONTEXT THERAPEUTICS INC More: the full row for CONTEXT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 373,835 shares; 2024Q4: 351,094 shares; 2025Q1: 351,094 shares; 2025Q2: 351,094 shares; 2025Q3: 351,094 shares; 2025Q4: 351,094 shares; 2026Q1: 351,094 shares; 2026Q2: 750,969 shares 750,969 $416K 0.02% +399,875 Timeline STIP ISHARES TR More: the full row for ISHARES TR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,000 shares 4,000 $409K 0.02% new Timeline KLRS KALARIS THERAPEUTICS INC More: the full row for KALARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares 100,000 $407K 0.02% 0 Timeline BCAX BICARA THERAPEUTICS INC More: the full row for BICARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 40,440 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,875 shares; 2025Q3: 13,705 shares; 2025Q4: 13,705 shares; 2026Q1: 13,705 shares; 2026Q2: 13,705 shares 13,705 $407K 0.02% 0 Timeline MRK MERCK & CO INC More: the full row for MERCK & CO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,140 shares; 2024Q4: 2,440 shares; 2025Q1: not reported; 2025Q2: 7,040 shares; 2025Q3: 18,540 shares; 2025Q4: 9,640 shares; 2026Q1: 3,140 shares; 2026Q2: 3,140 shares 3,140 $403K 0.02% 0 Timeline NMRA NEUMORA THERAPEUTICS INC. More: the full row for NEUMORA THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 68,608 shares; 2025Q1: 26,108 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,600 shares; 2026Q1: 33,100 shares; 2026Q2: 210,000 shares 210,000 $357K 0.02% +176,900 Timeline IRTC IRHYTHM HOLDINGS INC More: the full row for IRHYTHM HOLDINGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,000 shares 3,000 $357K 0.02% new Timeline ACHV ACHIEVE LIFE SCIENCE INC More: the full row for ACHIEVE LIFE SCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 91 shares; 2024Q4: 13,173 shares; 2025Q1: 43,173 shares; 2025Q2: 43,173 shares; 2025Q3: 47,800 shares; 2025Q4: 47,800 shares; 2026Q1: 47,800 shares; 2026Q2: 53,800 shares 53,800 $351K 0.02% +6,000 Timeline BABA ALIBABA GROUP HLDG LTD More: the full row for ALIBABA GROUP HLDG LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,578 shares; 2025Q4: 3,578 shares; 2026Q1: 3,578 shares; 2026Q2: 3,578 shares 3,578 $343K 0.02% 0 Timeline WW WW INTL INC More: the full row for WW INTL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 52,450 shares; 2025Q4: 57,100 shares; 2026Q1: 57,700 shares; 2026Q2: 21,300 shares 21,300 $340K 0.02% -36,400 Timeline CNSP CNS PHARMACEUTICALS INC More: the full row for CNS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 70,000 shares 70,000 $335K 0.02% new Timeline CBIO CRESCENT BIOPHARMA INC. More: the full row for CRESCENT BIOPHARMA INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 606,000 shares; 2026Q1: 50,273 shares; 2026Q2: 18,275 shares 18,275 $329K 0.02% -31,998 Timeline BSX BOSTON SCIENTIFIC CORP More: the full row for BOSTON SCIENTIFIC CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,500 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,000 shares; 2026Q1: 10,000 shares; 2026Q2: 7,500 shares 7,500 $320K 0.02% -2,500 Timeline ALT ALTIMMUNE INC More: the full row for ALTIMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 102,823 shares 102,823 $313K 0.01% new Timeline VSTM VERASTEM INC More: the full row for VERASTEM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 71,100 shares; 2026Q2: 75,800 shares 75,800 $290K 0.01% +4,700 Timeline ANTX AN2 THERAPEUTICS INC More: the full row for AN2 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 13,861 shares; 2026Q2: 58,808 shares 58,808 $285K 0.01% +44,947 Timeline DERM JOURNEY MED CORP More: the full row for JOURNEY MED CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 39,517 shares 39,517 $280K 0.01% new Timeline PROCAP ACQUISITION CORP PROCAP ACQUISITION CORP More: the full row for PROCAP ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,680 shares; 2025Q3: 26,940 shares; 2025Q4: 26,940 shares; 2026Q1: 26,940 shares; 2026Q2: 26,940 shares 26,940 $279K 0.01% 0 PMVP PMV PHARMACEUTICALS INC More: the full row for PMV PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 101,008 shares; 2024Q4: 101,008 shares; 2025Q1: 101,008 shares; 2025Q2: 101,008 shares; 2025Q3: 101,008 shares; 2025Q4: 101,008 shares; 2026Q1: 231,008 shares; 2026Q2: 201,008 shares 201,008 $269K 0.01% -30,000 Timeline CMPX COMPASS THERAPEUTICS INC More: the full row for COMPASS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 25,000 shares; 2025Q3: 50,000 shares; 2025Q4: 139,000 shares; 2026Q1: 139,000 shares; 2026Q2: 122,132 shares 122,132 $267K 0.01% -16,868 Timeline JD JD.COM INC More: the full row for JD.COM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares 10,000 $255K 0.01% 0 Timeline RZLT REZOLUTE INC More: the full row for REZOLUTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,571,705 shares; 2024Q4: 1,359,208 shares; 2025Q1: 1,116,047 shares; 2025Q2: 989,297 shares; 2025Q3: 815,975 shares; 2025Q4: 38,679 shares; 2026Q1: 58,679 shares; 2026Q2: 48,679 shares 48,679 $253K 0.01% -10,000 Timeline ANAB ANAPTYSBIO INC More: the full row for ANAPTYSBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 192,720 shares; 2024Q4: 27,301 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,698 shares; 2026Q2: 3,698 shares 3,698 $250K 0.01% 0 Timeline NGNE NEUROGENE INC More: the full row for NEUROGENE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 553 shares; 2024Q4: not reported; 2025Q1: 27,925 shares; 2025Q2: 29,625 shares; 2025Q3: 30,633 shares; 2025Q4: 30,633 shares; 2026Q1: not reported; 2026Q2: 7,800 shares 7,800 $245K 0.01% new Timeline IHI ISHARES TR More: the full row for ISHARES TR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,900 shares 4,900 $242K 0.01% new Timeline RXST RXSIGHT INC More: the full row for RXSIGHT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 21,803 shares; 2026Q1: 43,250 shares; 2026Q2: 50,000 shares 50,000 $241K 0.01% +6,750 Timeline COYA COYA THERAPEUTICS INC More: the full row for COYA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,900 shares; 2026Q2: 40,900 shares 40,900 $239K 0.01% 0 Timeline BCYC BICYCLE THERAPEUTICS PLC More: the full row for BICYCLE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 71,298 shares; 2026Q2: 50,638 shares 50,638 $215K 0.01% -20,660 Timeline CEPS CANTOR EQUITY PARTNERS VI IN More: the full row for CANTOR EQUITY PARTNERS VI IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,000 shares; 2026Q2: 20,000 shares 20,000 $207K 0.01% 0 Timeline SCYX SCYNEXIS INC More: the full row for SCYNEXIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 49,387 shares 49,387 $201K 0.01% new Timeline PSNL PERSONALIS INC More: the full row for PERSONALIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 25,000 shares; 2026Q2: 15,000 shares 15,000 $201K 0.01% -10,000 Timeline QCLS Q/C TECHNOLOGIES INC More: the full row for Q/C TECHNOLOGIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares 50,000 $195K 0.01% 0 Timeline CABA CABALETTA BIO INC More: the full row for CABALETTA BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares 50,000 $156K 0.01% new Timeline RXRX RECURSION PHARMACEUTICALS IN More: the full row for RECURSION PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,000 shares; 2024Q4: 15,000 shares; 2025Q1: 15,000 shares; 2025Q2: 35,000 shares; 2025Q3: 35,000 shares; 2025Q4: 35,000 shares; 2026Q1: 35,000 shares; 2026Q2: 41,000 shares 41,000 $150K 0.01% +6,000 Timeline OGN ORGANON & CO More: the full row for ORGANON & CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,100 shares; 2024Q4: 40,200 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 35,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares 10,000 $135K 0.01% 0 Timeline MIST MILESTONE PHARMACEUTICALS IN More: the full row for MILESTONE PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 27,931 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,100 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares 100,000 $134K 0.01% 0 Timeline NEUP NEUPHORIA THERAPEUTICS INC More: the full row for NEUPHORIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares; 2026Q2: 30,000 shares 30,000 $131K 0.01% 0 Timeline STIM NEURONETICS INC More: the full row for NEURONETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares 100,000 $130K 0.01% 0 Timeline CMMB CHEMOMAB THERAPEUTICS LTD More: the full row for CHEMOMAB THERAPEUTICS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 80,000 shares; 2026Q1: 80,000 shares; 2026Q2: 80,000 shares 80,000 $130K 0.01% 0 Timeline VYGR VOYAGER THERAPEUTICS INC More: the full row for VOYAGER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 40,634 shares; 2024Q4: 126,792 shares; 2025Q1: 75,545 shares; 2025Q2: 79,945 shares; 2025Q3: 35,000 shares; 2025Q4: 35,000 shares; 2026Q1: 35,000 shares; 2026Q2: 35,000 shares 35,000 $122K 0.01% 0 Timeline TRDA ENTRADA THERAPEUTICS INC More: the full row for ENTRADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 30,500 shares; 2026Q2: 15,500 shares 15,500 $114K 0.01% -15,000 Timeline VERU VERU INC More: the full row for VERU INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,000 shares; 2026Q1: 35,000 shares; 2026Q2: 35,000 shares 35,000 $110K 0.01% 0 Timeline CAES CANTOR EQUITY PARTNERS VII I More: the full row for CANTOR EQUITY PARTNERS VII I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,000 shares 10,000 $101K <0.01% new Timeline CLNN CLENE INC More: the full row for CLENE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 15,000 shares 15,000 $92.3K <0.01% new Timeline VTGN VISTAGEN THERAPEUTICS INC More: the full row for VISTAGEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 163,078 shares; 2024Q4: 121,461 shares; 2025Q1: 420,765 shares; 2025Q2: 420,765 shares; 2025Q3: 113,062 shares; 2025Q4: 623,575 shares; 2026Q1: 751,141 shares; 2026Q2: 351,141 shares 351,141 $79.4K <0.01% -400,000 Timeline LGVN LONGEVERON INC More: the full row for LONGEVERON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares; 2026Q2: 108,406 shares 108,406 $76.2K <0.01% -91,594 Timeline BMEA BIOMEA FUSION INC More: the full row for BIOMEA FUSION INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 43,420 shares; 2026Q1: 43,420 shares; 2026Q2: 43,420 shares 43,420 $63.8K <0.01% 0 Timeline LITS LITE STRATEGY INC More: the full row for LITE STRATEGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 292,397 shares; 2025Q4: 67,292 shares; 2026Q1: 67,292 shares; 2026Q2: 67,292 shares 67,292 $62.1K <0.01% 0 Timeline JSPR JASPER THERAPEUTICS INC More: the full row for JASPER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,816 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 140,000 shares; 2026Q1: 140,000 shares; 2026Q2: 140,000 shares 140,000 $58.9K <0.01% 0 Timeline ARDX ARDELYX INC More: the full row for ARDELYX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 6,400 shares; 2024Q4: 31,035 shares; 2025Q1: 490,743 shares; 2025Q2: 915,130 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 23,900 shares; 2026Q2: 11,000 shares 11,000 $56.1K <0.01% -12,900 Timeline GOSS GOSSAMER BIO INC More: the full row for GOSSAMER BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 416,958 shares; 2024Q4: 295,613 shares; 2025Q1: 227,228 shares; 2025Q2: 227,228 shares; 2025Q3: 212,531 shares; 2025Q4: 212,531 shares; 2026Q1: 287,531 shares; 2026Q2: 212,531 shares 212,531 $35K <0.01% -75,000 Timeline ATYR ATYR PHARMA INC More: the full row for ATYR PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 175,000 shares; 2025Q4: 50,685 shares; 2026Q1: 50,685 shares; 2026Q2: 50,685 shares 50,685 $30.2K <0.01% 0 Timeline ASPCR A SPAC III ACQUISITION CORP More: the full row for A SPAC III ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 215,000 shares; 2025Q2: 215,000 shares; 2025Q3: 215,000 shares; 2025Q4: 215,000 shares; 2026Q1: 215,000 shares; 2026Q2: 215,000 shares 215,000 $19.1K <0.01% 0 Timeline PRQR PROQR THRAPEUTICS N V More: the full row for PROQR THRAPEUTICS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 20,394 shares; 2025Q1: 20,394 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares 10,000 $18.6K <0.01% 0 Timeline BSAAR BEST SPAC I ACQUISITION CORP More: the full row for BEST SPAC I ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares 100,000 $16.6K <0.01% new Timeline CHRS COHERUS ONCOLOGY INC More: the full row for COHERUS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,366 shares; 2025Q3: 10,366 shares; 2025Q4: 10,366 shares; 2026Q1: 10,366 shares; 2026Q2: 10,366 shares 10,366 $14.5K <0.01% 0 Timeline